Patents by Inventor Linda Clayton

Linda Clayton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220368624
    Abstract: The technologies described herein are generally directed to modeling radio wave propagation in a fifth generation (5G) network or other next generation networks. For example, a method described herein can include, facilitating receiving a disabling request for a first time period and applicable to a first service element in a first service path of first service elements to provide a service. The method can further include identifying, by the configuration equipment, and scheduled change data, a second service element from a combined group of the first and second service elements of a second service path for the provision of the service. Further, based on a first determination that the second service element is to be disabled during the first time period, facilitating disabling the first service element during a second time period where the second service element is not disabled.
    Type: Application
    Filed: May 17, 2021
    Publication date: November 17, 2022
    Inventors: Stephen Wolyn, Gur Rotkop, Linda Clayton, Kun-Tsun Chen, Qun Luo, Rakesh Sinha, Carlos Eduardo De Andrade, Gilbert Figueroa, Prasanna Ramachandran
  • Patent number: 7247438
    Abstract: Methods for identifying agents which enhance the activity of a caspase according to the invention are described, as well as methods for enhancing caspase activity and methods for enhancing apoptosis in a lymphocyte.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: July 24, 2007
    Assignee: Dana-Farber Cancer Institute
    Inventors: Ellis Reinherz, Linda Clayton, Timothy D. Ocain, Raymond J. Patch
  • Publication number: 20050084916
    Abstract: The identification of a novel gene, termed I?BNS, regulated during negative selection of immature CD4+CD8+double positive (DP) thymocytes in mice, and the human homolog of the gene, are described, along with the gene products produced by these genes. Methods of using the disclosed genes and gene products are also described.
    Type: Application
    Filed: February 20, 2004
    Publication date: April 21, 2005
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Ellis Reinherz, Linda Clayton, Emma Fiorini, Pedro Reche, Ingo Schmitz